Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Shipment Delays Threaten the Best Advantage Novavax Has

The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage.

If Solana Pay Doesn’t Change the Fortunes of SOL What Will?

The launch of Solana Pay isn't shielding SOL-USD from the broader sell-off. That could be a harbinger of even more downward pressure to come.

Does the Reward in Paysafe Stock Outweigh the Substantial Risk?

If you buy into the thesis that sectors currently out of favor won’t stay that way, then the reward with PSFE stock may outweigh the risk.

7 Tech Stocks Set for Strong Gains in February

Now is the time for investors to look for quality tech sector names. These tech stocks are bouncing back and ready to deliver solid gains.

Nvidia Offers Offers Clarity in an Uncertain Economy

Nvidia may face forces that are outside of its control. But none of those forces are likely to have much effect on NVDA stock.